P029-0191 Screening compound: 5-[5-(4,5,6,7-tetrahydro-1H-indazol-3-yl)-1,2,4-oxadiazol-3-yl]-1,2-dihydropyridin-2-one

P029-0191 Screening compound: 5-[5-(4,5,6,7-tetrahydro-1H-indazol-3-yl)-1,2,4-oxadiazol-3-yl]-1,2-dihydropyridin-2-one
P029-0191 Screening compound: 5-[5-(4,5,6,7-tetrahydro-1H-indazol-3-yl)-1,2,4-oxadiazol-3-yl]-1,2-dihydropyridin-2-one alternative view

Chemical Structure Depiction of ChemDiv screening compound P029-0191
5-[5-(4,5,6,7-tetrahydro-1H-indazol-3-yl)-1,2,4-oxadiazol-3-yl]-1,2-dihydropyridin-2-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P029-0191

Molecular Formula

C14H13N5O2 (C14 H13 N5 O2)

Compound Name

5-[5-(4,5,6,7-tetrahydro-1H-indazol-3-yl)-1,2,4-oxadiazol-3-yl]-1,2-dihydropyridin-2-one

IUPAC name

5-[5-(4567-tetrahydro-1H-indazol-3-yl)-124-oxadiazol-3-yl]-12-dihydropyridin-2-one

SMILES

O=C(C=C1)NC=C1c1noc(-c2n[nH]c3c2CCCC3)n1

InChI

InChI=1S/C14H13N5O2/c20-11-6-5-8(7-15-11)13-16-14(21-19-13)12-9-3-1-2-4-10(9)17-18-12/h5-7H,1-4H2,(H,15,20)(H,17,18)

InChI Key

SLQHIWDCTFKPMH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27559112

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

283.29

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

2.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

1.487

Distribution Coefficient, logD

1.486

Water Solubility, LogSw

-1.78

Polar Surface Area

81.307

Acid Dissociation Constant (pKa)

11.13

Base Dissociation Constant (pKb)

-0.57

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

28.60

P029-0191 in Drug Discovery

Included in Screening Libraries

Angiogenesis library (14822 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with P029-0191 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P029-0191?
Check Price and Availability of P029-0191, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P029-0191 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P029-0191
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P029-0191
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P029-0191 available by request